The Weekly Dose, 20 Nov 2026
Measles returns to the US, Bentham's aching jaw and 125,000-year-old poisoned spears.
A big week for outbreaks, pills and things that refuse to stay buried.
🤯 Weird and wonderful
- CT scans of philosopher Jeremy Bentham's preserved head show many missing teeth and an arthritic jaw. He died in 1832. Curators think he lived in real pain. The "greatest happiness" man, with toothache.
- Stone points from a 125,000-year-old Saudi lake site carry traces of a heart-stopping arrow-poison tree. The oldest known poisoned weapons were about 60,000 years old. Surface finds, so the age is inferred. Pharmacology, aimed at hippos.
- A Neanderthal gene variant common today goes with a slightly smaller occipital lobe and almost 10% lower schizophrenia risk in people with two copies. Genetic association study, PNAS. Ancient lodgers, still rearranging the furniture.
- EEG caught out-of-body experiences as 35 volunteers drifted off: 20 reported odd body sensations, including 10 episodes of floating outside the body. Small study. They signalled with eye movements, mid-float. Impressive multitasking.
🩺 This week in health news
- The US, Mexico and Bolivia have officially lost measles elimination status, as the Americas logged 58,213 cases this year to 13 November. Same period last year: 12,806. There have been 82 deaths. Elimination, it turns out, needs renewing: two doses at a time.
- The Bundibugyo virus epidemic in DR Congo, a member of the Ebola family, has passed 11,000 cases and 5,400 deaths in six months. Children make up over a quarter of cases and a third of deaths. The existing Ebola vaccine isn't approved for this species; candidates are joining a trial.
- The FDA approved giredestrant, a hormone-blocking pill, with everolimus for advanced ER-positive breast cancer with an ESR1 mutation: 10.0 versus 5.5 months before progression. The mutation is found with a blood test. Personalised medicine that's actually personal.
- Across 15 countries in the Americas, carbapenem resistance in Klebsiella pneumoniae rose from about 15% in 2015 to 26% in 2024. Carbapenems are often the last reliable option. It's World AMR Awareness Week. The bugs are doing their homework.
📺 In the media
- Australia's TGA approved orforglipron, a daily GLP-1 weight-loss pill. What's actually true: in its main trial people lost 7.5–11.2% of body weight over 72 weeks, versus 2.1% on placebo. Less than the injections, no needle, no food rules, and not PBS-subsidised.
- England's NICE has draft-recommended the "sponge on a string" test for some people with long-term reflux. What's actually true: you swallow a capsule, it becomes a sponge and collects cells as it's pulled back up. It checks for Barrett's oesophagus, a precancer. Positives still need an endoscopy.
- Of 50 UK companies selling health tests to healthy people, about 70% gave no information on limitations or harms. What's actually true: 12 offered mammograms to symptom-free women under 50. False alarms lead to more tests, worry and cost. More testing isn't automatically more health.
- US authorities are moving to restrict concentrated 7-OH, a potent opioid-like compound made from kratom. What's actually true: the DEA notice targets high-strength 7-OH products, not plain kratom leaf, citing dozens of serious harm reports. "Natural" and "safe" remain different words.
🔬 New research
- Extra time, breaks, quiet desks and standing desks didn't improve behaviour or schoolwork in children with ADHD; medication and behaviour therapy did. Crossover RCT, 255 children, JAMA Pediatrics. They cut rule-breaking by 37% and 61%. Why it matters: accommodations alone may not be enough. Summer-school setting.
- Village health workers who could prescribe kept blood pressure as well controlled as nurse-led clinics: 78% versus 74% at 12 months. Cluster RCT, 807 adults in 103 villages in rural Lesotho (82% women), Lancet Global Health. Why it matters: care can reach people who can't reach clinics.
- Hyoscine butylbromide or sodium bicarbonate in labour didn't raise the spontaneous birth rate after induction (61%, 61% and 57% versus 56% on placebo). Double-blind factorial RCT, 2,963 first-time mothers, Norway, BMJ. Why it matters: authors advise against routine use.
- Cannabidiol oil didn't calm severe behaviour problems in children with intellectual disability. Double-blind RCT, 131 children at 3 Australian hospitals, JAMA Pediatrics. Why it matters: families pay a lot for it. For the week's big trials, see the Research hub.
🐝 Beyond humans
- Oregon found H5N1 bird flu in a dairy herd, making it the 22nd US state with infected cattle. Routine milk testing caught it. Washington's dairy outbreak has included human infections. Milk surveillance: the least glamorous pandemic early-warning system, and one of the best.
- Genomes traced a cruise-ship hantavirus outbreak to rodents in Patagonia, then person-to-person spread on board. Two Science papers. Andes virus is the only hantavirus known to pass between people.
- Reintroduced Swiss lynx carry a recessive gene that causes fatal organ calcification in young cats. The population descends from about 30 founders. The same founder effect drives some rare human diseases. Conservation genetics, meet clinical genetics.
- Nearly 1 in 3 brown rats sampled in 8 French cities carried rat hepatitis E (209 of 686). Rat strains closely matched human ones. It can cause hepatitis in people and is easy to miss on standard tests. Wash hands after handling rats, pet ones included.
💡 Useful things
- Check your measles vaccines before you travel. Two doses give strong protection. If you're not sure you've had them, ask your doctor; a catch-up dose is usually simple.
- Heartburn most days isn't a lifestyle. See a GP if pharmacy medicines aren't helping, food gets stuck, you're often sick or you're losing weight without trying.
- A tape measure beats the scales for some risks. Measure midway between your lowest rib and hip bone, after breathing out. Over 94 cm (men) or 80 cm (women) signals higher heart risk.
- Before buying a health test, ask what you'd do with the result. If the answer is "nothing different", or the seller won't say how accurate it is, keep your money.
🦓 Zebras
- Niemann-Pick type C traps cholesterol inside cells, about 1 in 100,000 people. This week the FDA approved adrabetadex for the infantile form: median survival 8.5 versus 4.9 years against external controls.
- In fibrodysplasia ossificans progressiva, muscles and tendons slowly turn to bone. The early clue is at birth: malformed big toes. About 1 in a million people.
- Takayasu arteritis, "pulseless disease", inflames the aorta and its branches until a wrist pulse can vanish. 80–90% of patients are women, often young. About 1 in 75,000 in Europe (Orphanet).
- Vascular Ehlers-Danlos syndrome makes arteries and hollow organs fragile; thin skin with visible veins can be a clue. About 1 in 50,000 to 250,000 people. Not the same as everyday hypermobility.
🧠 Deep dives this week
- Hypermobility: hEDS and HSD 20 Nov, for clinicians: Beighton limits, no hEDS gene yet, vascular red flags and what rehab shows.
- ME/CFS 17 Nov, for clinicians: Post-exertional malaise, COVID triggers, DecodeME, PACE vs NICE and failed trials.
📅 Coming up
- 22 Nov: 22q11.2 Awareness Day: one small deletion, many body systems. 🧩 themed puzzles
- 25 Nov–10 Dec: 16 Days of Activism against Gender-Based Violence. If you need support in Australia, call 1800RESPECT (1800 737 732); in an emergency, call 000 or your local emergency number.
- 1 Dec: World AIDS Day: test, treat, prevent. 🧩 themed puzzles
- 3 Dec: International Day of Persons with Disabilities. 🧩 themed puzzles
🧩 Puzzles this week
- Sat 21 Nov: Einstein Sudokrine, the first Sensitosis Saturday (all five tests) and Cryptoplexy #5.
- Sun 22 Nov: Einstein Grand Rounds #6, plus Genius Triviosis for 22q11.2 Day.
- Wed 25 and Thu 26 Nov: Super Zebritis, then Einstein Arrhythmix and Long Linkase.
- Daily: 🫀 Stackulus: everyone gets the same organs and one scored go. Top the world board.
Malady Wise · Curiosity is contagious.
General education, not personal medical advice.
Sources
- PAHO (measles elimination, 17 Nov 2026)
- WHO Director-General (Bundibugyo virus disease, 17 Nov 2026)
- FDA (giredestrant with everolimus)
- PAHO (antibiotic resistance in the Americas, 18 Nov 2026)
- The Nightly (TGA approval) · Pharmaceutical Journal (trial results)
- Cancer Research UK (NICE draft, capsule sponge)
- BMJ Group via EurekAlert! (BMJ Open, consumer health tests)
- US Federal Register (DEA notice on 7-OH)
- JAMA Pediatrics (ADHD accommodations trial)
- Lancet Global Health (Lesotho hypertension trial)
- BMJ (SAINT trial)
- JAMA Pediatrics (cannabidiol trial)
- UCL (Bentham CT scans)
- Science (poisoned points, Arabia)
- PNAS (Neanderthal variant)
- Consciousness and Cognition (out-of-body EEG)
- Oregon Department of Agriculture (H5N1 in dairy cattle)
- Science (Andes virus outbreak genomics)
- Nature Ecology & Evolution (lynx)
- Emerging Infectious Diseases (rat hepatitis E, France)
- Healthdirect · NHS · Heart Foundation
- MedlinePlus Genetics (FOP) · Vasculitis UK (Takayasu) · StatPearls (Ehlers-Danlos syndromes) · Orphanet frequencies via our rare conditions list